display ongoing
results: demonstrated suggested inconclusive safety concern ongoing study
metastatic/advanced OC (mOC) - maintenance (M)
metastatic/advanced OC (mOC) - maintenance (M)
immune chekpoint inhibitors
anti-PD-(L)1
avelumab based treatment
avelumab plus SoC JAVELIN Ovarian 100

Study type:

 

- About us - Contact us - Method - RSS Made with in Lyon - Credits - Privacy policy - Licence Creative Commons